Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients With Iron Deficiency Anemia
Arooj Khan
198 participants
Jan 10, 2024
INTERVENTIONAL
Summary
This study aims to compare the efficacy of two iron preparation for the management of children presented with iron deficiency anemia. Ferrous sulphate and lron polymaltose (ferric form) are most commonly used preparations. Both drugs are easily available in market and are often recommended by pediatriclans. The efficacy, bioavail.tbilily, side effects and cost of these preparations vary. This study is designed to find out a drug with better efficacy that can be used for treatment of iron deficiency anemia in local population.
Eligibility
Inclusion Criteria1
- Patients having iron deficiency anemia
Exclusion Criteria4
- Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record).
- Patients who were transfused in previous 4 weeks (will be determined on history)
- Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record)
- Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ferrous sulphate in a dose of 6mg/kg/day of elemental iron once daily for 8 weeks orally in syrup form.
Iron Polymaltose complex in a dose of 6mg/kg/day of elemental iron once daily orally for 8 weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06742528